Advertisement

Diabetologia

, Volume 34, Issue 11, pp 822–829 | Cite as

The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of Type 1 (insulin-dependent) diabetes mellitus

  • D. Ziegler
  • P. Mayer
  • H. Mühlen
  • F. A. Gries
Originals

Summary

The natural evolution of neural dysfunction was studied prospectively over 5 years following diagnosis of Type 1 (insulin-dependent) diabetes in 32 patients aged 12–36 years. Motor and sensory nerve conduction velocities, heart rate variation at rest and during deep breathing, and pupillary function were measured at diagnosis and after 3,12, 24,48, and 60 months. Thermal and vibration sensation thresholds were determined after 24, 48, and 60 months of diabetes. Mean HbA1 levels of months 3–60 within the normal range of <8.3% (7.3±0.2%) were observed in 13 patients (Group 1), while a mean HbA1 of months 3–60≥8.3% (10.0±0.3%) was found in 19 patients (Group 2). Mean nerve conduction was significantly diminished in Group 2 as compared with Group 1 in at least 4 out of 6 nerves tested during months 12–60 (p<0.05). Both tests of heart rate variation were significantly impaired in Group 2 as compared with Group 1 after 24 and 60 months (p<0.05), but no differences in pupillary function were observed between the groups. Thermal discrimination but not vibration perception thresholds on the foot were significantly higher in Group 2 than in Group 1 at 40 and 60 months (p<0.05). Abnormalities in nerve conduction, thermal discrimination, and heart rate variation, but not vibration perception threshold and the pupillary function tests were significantly more frequent in Group 2 than in Group 1 at 60 months (p<0.05). After 60 months, none of the patients of Group 1, but 6 and 4 patients of Group 2 developed subclinical or symptomatic neuropathy, respectively (p<0.05). These findings suggest that the evolution of subclinical and symptomatic neuropathy during the first 5 years after diagnosis of Type 1 diabetes may be predicted by poor glycaemic control and prevented by near-normoglycaemia.

Key words

Diabetic neuropathy glycaemic control nerve conduction autonomic function sensory thresholds 

References

  1. 1.
    Ewing DJ, Campbell IW, Clarke BF (1980) The natural history of diabetic autonomic neuropathy. Q J Med 49: 95–108PubMedGoogle Scholar
  2. 2.
    Navarro X, Kennedy WR, Loewenson RB, Sutherland DER (1990) Influence of pancreas transplantation on cardiorespiratory reflexes, nerve conduction, and mortality in diabetes mellitus. Diabetes 39: 802–806PubMedGoogle Scholar
  3. 3.
    Committee on Health Care Issues, American Neurological Association (1986) Does improved control of glycemia prevent or ameliorate diabetic polyneuropathy? Ann Neurol 19: 288–290Google Scholar
  4. 4.
    The DCCT Research Group (1988) Are continuing studies of metabolic control and microvascular complications in insulin-dependent diabetes mellitus justified? N Engl J Med 318: 246–250Google Scholar
  5. 5.
    Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF et al. (1986) Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. Br Med J 293: 1195–1199Google Scholar
  6. 6.
    Ziegler D, Wiefels K, Dannehl K, Gries FA and the Düsseldorf Study Group (1988) Effects of one year of near-normoglycemia on peripheral nerve function in Type 1 (insulin-dependent) diabetic patients. Klin Wochenschr 66: 388–396PubMedGoogle Scholar
  7. 7.
    Service FJ, Rizza RA, Daube JR, O'Brien PC, Dyck PJ (1985) Near normoglycaemia improved nerve conduction and vibration sensation in diabetic neuropathy. Diabetologia 28: 722–727PubMedGoogle Scholar
  8. 8.
    Jakobsen J, Christiansen JS, Kristoffersen I et al. (1988) Autonomic and somatosensory nerve function after 2 years of continuous subcutaneous insulin infusion in Type 1 diabetes. Diabetes 37: 452–455PubMedGoogle Scholar
  9. 9.
    Kennedy WR, Navarro X, Goetz FC, Sutherland DER, Najarian JS (1990) Effects of pancreatic transplantation on diabetic neuropathy. N Engl J Med 322: 1031–1037PubMedGoogle Scholar
  10. 10.
    Ward JC, Barnes CG, Fisher DJ, Jessop JD, Baker RWR (1971) Improvement in nerve conduction following treatment in newly diagnosed diabetics. Lancet I: 428–431CrossRefGoogle Scholar
  11. 11.
    Ziegler D, Cicmir I, Mayer P, Wiefels K, Gries FA (1986) Peripheral and autonomic nerve dysfunction in newly diagnosed insulin-dependent diabetes. Transplant Proc 18: 1593–1594Google Scholar
  12. 12.
    Porte D, Graf RJ, Halter JB, Pfeifer MA, Halar E (1981) Diabetic neuropathy and plasma glucose control. Am J Med 70: 195–200CrossRefPubMedGoogle Scholar
  13. 13.
    Ziegler D, Mayer P, Gries FA (1988) Evaluation of thermal, pain, and vibration sensation thresholds in newly diagnosed Type 1 diabetic patients. J Neurol Neurosurg Psychiat 51: 1420–1424PubMedGoogle Scholar
  14. 14.
    Newrick PG, Boulton ATM, Ward JD (1987) Nerve ischaemiaresistance: an early abnormalities in diabetes. Diabetic Med 4: 517–520PubMedGoogle Scholar
  15. 15.
    Fraser DM, Campbell IW, Ewing DJ, Murray A, Neilson JMM, Clarke BF (1977) Peripheral and autonomic nerve function in newly diagnosed diabetes mellitus. Diabetes 26: 546–550PubMedGoogle Scholar
  16. 16.
    Lehtinen JM, Uusitupa M, Siitonen O, Pyörälä K (1989) Prevalence of neuropathy in newly diagnosed NIDDM and nondiabetic control subjects. Diabetes 38: 1307–1313PubMedGoogle Scholar
  17. 17.
    Frost-Larsen K, Sandahl Christiansen J, Parving H-H (1983) The effect of strict short-term metabolic control on retinal nervous system abnormalities in newly diagnosed Type 1 (insulin-dependent) diabetic patients. Diabetologia 24: 207–209PubMedGoogle Scholar
  18. 18.
    Morguet A, Springer HJ (1981) Microcomputer-based measurement of beat-to-beat intervals and analysis of heart rate variability. Med Progr Technol 8: 77–82Google Scholar
  19. 19.
    Ziegler D, Cicmir I, Wiefels K, Berger H, Gries FA (1987) Peripheral and autonomic nerve function in long-term insulindependent diabetes. Diab Res 4: 9–14Google Scholar
  20. 20.
    Fruhstorfer H, Lindblom U, Schmidt WG (1976) Method for quantitative estimation of thermal thresholds in patients. J Neurol Neurosurg Psychiatr 39: 1071–1075PubMedGoogle Scholar
  21. 21.
    Ziegler D, Mayer P, Wiefels K, Gries FA (1988) Assessment of small and large fiber function in long-term type 1 (insulin-dependent) diabetic patients with and without painful neuropathy. Pain 34: 1–10CrossRefPubMedGoogle Scholar
  22. 22.
    Goldberg JM, Lindblom U (1979) Standardised method of determining vibratory perception thresholds for diagnosis and screening in neurological investigation. J Neurol Neurosurg Psychiatr 42: 793–803PubMedGoogle Scholar
  23. 23.
    Dyck PJ (1988) Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 11: 21–32PubMedGoogle Scholar
  24. 24.
    Pirart J (1987) Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diab Care 1: 168–188, 252–263Google Scholar
  25. 25.
    Hillson RM, Hockaday TDR, Newton DJ (1984) Hyperglycaemia is one correlate of deterioration in vibration sense during the 5 years after diagnosis of Type 2 (non-insulin-dependent) diabetes. Diabetologia 26: 122–126PubMedGoogle Scholar
  26. 26.
    Sima AAF, Nathaniel V, Bril V, McEwen TAGJ, Greene DA (1988) Histopathological heterogeneity of neuropathy in insulindependent and non-insulin-dependent diabetes and demonstration of axo-glial dysjunction in human diabetic neuropathy. J Clin Invest 81: 349–364PubMedGoogle Scholar
  27. 27.
    Dyck PJ, Karnes JL, Daube J, O'Brien P, Service FJ (1985) Clinical and neuropathological criteria for the diagnosis and staging of diabetic polyneuropathy. Brain 108: 861–880PubMedGoogle Scholar
  28. 28.
    Dyck PJ, Bushek W, Spring EM, Karnes JL, Litchy WJ, O'Brien PC, Service FJ (1987) Vibratory and cooling detection thresholds compared with other tests in diagnosing and staging diabetic neuropathy. Diab Care 10: 432–440Google Scholar
  29. 29.
    Gregersen G (1968) Variations in motor conduction velocity produced by acute changes of the metabolic state in diabetic patients. Diabetologia 4: 273–277PubMedGoogle Scholar
  30. 30.
    Comi G, Canal N, Lozza L et al. (1986) Peripheral nerve abnormalities in newly-diagnosed diabetic children. Acta Diabetol Lat 23: 69–75PubMedGoogle Scholar
  31. 31.
    Campbell IW, Fraser DM, Ewing DJ et al. (1976) Peripheral and autonomic nerve function in diabetic ketoacidosis. Lancet II: 167–169Google Scholar
  32. 32.
    Troni W, Carta Q, Cantello R, Caselle MT, Rainero I (1984) Peripheral nerve function and metabolic control in diabetes mellitus. Ann Neurol 16: 178–183PubMedGoogle Scholar
  33. 33.
    DCCT Research Group (1990) Diabetes Control and Complications Trial. Update. Diab Care 13: 427–433Google Scholar
  34. 34.
    The DCCT Research Group (1988) Factors in development of diabetic neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). Diabetes 37: 476–481Google Scholar
  35. 35.
    Mitchell BD, Hawthorne VM, Vinik AI (1990) Cigarette smoking and neuropathy in diabetic patients. Diab Care 13: 434–437Google Scholar
  36. 36.
    Dyck PJ, O'Brien PC (1989) Meaningful degrees of prevention or improvement of nerve conduction in controlled clinical trials of diabetic neuropathy. Diab Care 12: 649–652Google Scholar
  37. 37.
    Young RJ, Macintyre CCA, Martyn CN et al. (1986) Progression of subclinical polyneuropathy in young patients with Type 1 (insulin-dependent) diabetes: associations with glycaemic control and microangiopathy (microvascular complications). Diabetologia 29: 156–161PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1991

Authors and Affiliations

  • D. Ziegler
    • 1
  • P. Mayer
    • 1
  • H. Mühlen
    • 1
  • F. A. Gries
    • 1
  1. 1.Diabetes Research InstituteHeinrich-Heine-UniversityDüsseldorfFRG

Personalised recommendations